©The Author(s) 2025.
World J Nephrol. Sep 25, 2025; 14(3): 108406
Published online Sep 25, 2025. doi: 10.5527/wjn.v14.i3.108406
Published online Sep 25, 2025. doi: 10.5527/wjn.v14.i3.108406
Table 3 Summary of studies on salivary calcium and parathyroid hormone for chronic kidney disease diagnosis
| Ref. | Biomarker(s) | Sample size (CKD/control) | CKD stage(s) | Collection method | Statistical analysis | Correlation (r) | AUC | Assay type | Key findings | Limitations |
| Rodrigues et al[65], 2016 | Calcium, PTH | 60/37 | Stage 5 | Stimulated (paraffin chewing) | T-test, pearson, simple linear regression | Calcium: -0.13, PTH: 0.03 | NR | Colorimetric | No significant correlation between serum and saliva | Small sample size |
| Rajolani et al[66], 2024 | Calcium, PTH | 29/0 | NR | Spitting method | Paired t-test, pearson's correlation | NR | NR | Enzymatic | No significant serum-saliva correlation for calcium and PTH | Healthy controls are needed for better comparison |
- Citation: Abu Raihan Uddin M, Tuan Ismail TS, Wan Nik WNFH, Arifin WN, Isa S. Saliva as a non-invasive biomarker for chronic kidney disease: Challenges and potential in disease monitoring. World J Nephrol 2025; 14(3): 108406
- URL: https://www.wjgnet.com/2220-6124/full/v14/i3/108406.htm
- DOI: https://dx.doi.org/10.5527/wjn.v14.i3.108406